Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection

With much of the world infected with or vaccinated against severe acute respiratory syndrome coronavirus 2 (commonly abbreviated SARS-CoV-2; abbreviated here SARS2), understanding the immune responses to the SARS2 spike (S) protein in different situations is crucial to controlling the pandemic. We s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajadi, Mohammad M., Myers, Amber, Logue, James, Saadat, Saman, Shokatpour, Narjes, Quinn, James, Newman, Michelle, Deming, Meagan, Rikhtegaran Tehrani, Zahra, Magder, Laurence S., Karimi, Maryam, Abbasi, Abdolrahim, Shlyak, Mike, Baracco, Lauren, Frieman, Matthew B., Crotty, Shane, Harris, Anthony D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769618/
https://www.ncbi.nlm.nih.gov/pubmed/36321826
http://dx.doi.org/10.1128/msphere.00279-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769618/
https://www.ncbi.nlm.nih.gov/pubmed/36321826
http://dx.doi.org/10.1128/msphere.00279-22

Ejemplares similares